503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.08%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
4.29%
Cost growth less than half of CRWV's 19.16%. David Dodd would verify if cost advantage is structural.
0.99%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
-1.06%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
3.69%
R&D change of 3.69% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
16.59%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
6.79%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
114.81%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
6.98%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
5.69%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
17.06%
Interest expense growth above 1.5x CRWV's 1.19%. Michael Burry would check for over-leverage.
-1.45%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-100.19%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-6.65%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-131.13%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-130.50%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
485.71%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-126.94%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-126.40%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-6.07%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-164.09%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-162.79%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-165.57%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-165.57%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-1.30%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-2.14%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.